BAFF Protein (AA 127-309) (DYKDDDDK Tag)
Kurzübersicht für BAFF Protein (AA 127-309) (DYKDDDDK Tag) (ABIN925094)
Target
Alle BAFF (TNFSF13B) Proteine anzeigenProtein-Typ
Spezies
Quelle
Reinheit
-
-
Proteineigenschaft
- AA 127-309
-
Aufreinigungstag / Konjugat
- Dieses BAFF Protein ist gelabelt mit DYKDDDDK Tag.
-
Produktmerkmale
- Mediates splenocyte survival. Binds to mouse and human (weak) BCMA, TACI and BAFF-R. Host: The extracellular domain of mouse BAFF (AA 127-309) is fused at the N-terminus to a linker peptide (10 AA) and a DYKDDDDK tag.
-
Endotoxin-Niveau
- <0.1 EU/µg of purified protein (LAL test).
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!ProduktExpressionssystemKonjugatOriginPreis abExpressionssystem Cell-free protein synthesis (CFPS)Konjugat Strep TagOrigin MousePreis ab 15.754,29 €Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B) (AA 141-285), (Trimer) (Active) protein (His-DYKDDDDK Tag)
TNFSF13B Spezies: Human Wirt: HEK-293 Cells Recombinant > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC Active
Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B) (AA 99-330) protein (Fc Tag)TNFSF13B Spezies: Human Wirt: HEK-293 Cells Recombinant The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining. ScA, IA, ADA, AM
Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B) (Trimer) protein (His-Avi Tag,Biotin)TNFSF13B Spezies: Human Wirt: HEK-293 Cells Recombinant > 95% as determined by Tris-Bis PAGE,> 94% as determined by HPLC
Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B) (AA 141-285), (Trimer) (Active) protein (hFc-DYKDDDDK Tag)TNFSF13B Spezies: Human Wirt: HEK-293 Cells Recombinant > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC Active
Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B) (AA 134-285) (Active) protein (Fc Tag)TNFSF13B Spezies: Human Wirt: HEK-293 Cells Recombinant > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC Active
Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B) (AA 141-285), (Trimer) (Active) protein (Biotin,His-Avi-DYKDDDDK Tag)TNFSF13B Spezies: Cynomolgus Wirt: HEK-293 Cells Recombinant > 90 % as determined by Bis-Tris PAGE,> 90 % as determined by HPLC Active
Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B) (AA 136-285) protein (His-DYKDDDDK-Strep II Tag)TNFSF13B Spezies: Human Wirt: HEK-293T Cells Recombinant SDS, WB, ELISA, PI
Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B) (AA 141-285), (Trimer) (Active) protein (His-Avi Tag)TNFSF13B Spezies: Cynomolgus Wirt: HEK-293 Cells Recombinant > 90 % as determined by Bis-Tris PAGE,> 90 % as determined by HPLC Active
Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B) (AA 127-309) (Active) proteinTNFSF13B Spezies: Maus Wirt: HEK-293 Cells Recombinant >90 % as determined by SDS-PAGE. Active
Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B) (AA 134-285) (Active) protein (AVI tag,Fc Tag,Biotin)TNFSF13B Spezies: Human Wirt: HEK-293 Cells Recombinant >95 % as determined by SDS-PAGE. Active
-
-
Applikationshinweise
- Mediates splenocyte survival. Binds to mouse and human (weak) BCMA, TACI and BAFF-R.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Soluble. Reconstitute with 100 µL of sterile water for 0.1 mg/mL solution. Further dilutions should be made with medium containing 5% fetal calf serum.
-
Buffer
- PBS
-
Lagerung
- -20 °C
-
-
- BAFF (TNFSF13B) (Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B))
-
Andere Bezeichnung
- BAFF
-
Hintergrund
- Synonyms: BlyS, TALL-1, THANK, zTNF4, TNFSF 13B/20, CD257
-
Molekulargewicht
- ~17 kDa as determined by SDS-PAGE
-
Pathways
- NF-kappaB Signalweg, Production of Molecular Mediator of Immune Response
Target
-
